首页|期刊导航|中国中医药信息杂志|基于IL-6/JAK2/STAT3信号通路探讨海昆肾喜胶囊治疗慢性肾脏病肾纤维化作用机制

基于IL-6/JAK2/STAT3信号通路探讨海昆肾喜胶囊治疗慢性肾脏病肾纤维化作用机制OA

Exploration on the Mechanism of Haikun Shenxi Capsules in the Treatment of Chronic Kidney Disease-associated Renal Fibrosis via the IL-6/JAK2/STAT3 Signaling Pathway

中文摘要英文摘要

目的 基于IL-6/JAK2/STAT3信号通路探讨海昆肾喜胶囊治疗慢性肾脏病(CKD)肾纤维化的作用机制.方法 将48只雄性C57BL/6小鼠随机分为空白组、模型组、海昆肾喜胶囊组(200 mg/kg)和氯沙坦钾组(10 mg/kg).除空白组外,其余各组予0.2%腺嘌呤饮食4周诱导CKD模型.给药组于造模同时灌胃相应药物,每日1次,连续8周.检测血肌酐、血尿素氮、血尿酸及丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)水平,计算肾脏指数及尿白蛋白肌酐比值(ACR),HE、Masson及天狼星红染色观察肾组织形态及纤维化情况,透射电镜观察肾组织超微结构,免疫荧光检测纤维连接蛋白(Fibronectin)、E-钙黏蛋白(E-cadherin)表达,转录组学筛选关键靶点及通路,ELISA检测肾组织白细胞介素(IL)-6、IL-1β、肿瘤坏死因子-α(TNF-α)含量,RT-qPCR检测IL-6、Janus激酶2(JAK2)、信号转导及转录激活因子3(STAT3)mRNA表达,Western blot检测IL-6、JAK2、p-JAK2、STAT3和p-STAT3蛋白表达.结果 与空白组比较,模型组血肌酐、血尿素氮、血尿酸、ALT水平及肾脏指数、ACR显著升高(P<0.05,P<0.01),肾组织结构受损,表现为肾小管管腔扩张、刷状缘脱落,间质胶原纤维增生,胶原沉积显著增加(P<0.01),肾小管上皮细胞坏死,胞质电子密度降低、空泡样变、核溶解,Fibronectin表达显著升高,E-cadherin表达显著降低(P<0.01);与模型组比较,海昆肾喜胶囊组和氯沙坦钾组血肌酐、血尿素氮、血尿酸水平及肾脏指数、ACR显著降低(P<0.05,P<0.01),肾小管空泡样变、管腔扩张及胶原沉积等情况改善,Fibronectin表达显著降低,E-cadherin表达显著升高(P<0.05,P<0.01).转录组测序结果显示,海昆肾喜胶囊可调控295个CKD相关差异表达基因,主要富集于JAK-STAT信号通路.ELISA结果表明,海昆肾喜胶囊和氯沙坦钾可显著降低肾组织IL-6、IL-1β、TNF-α含量(P<0.05,P<0.01).RT-qPCR结果显示,海昆肾喜胶囊和氯沙坦钾可下调IL-6和STAT3 mRNA表达(P<0.05,P<0.01).Western blot结果表明,两者均可抑制IL-6蛋白表达及JAK2、STAT3磷酸化水平(P<0.05,P<0.01).结论 海昆肾喜胶囊可能通过抑制IL-6/JAK2/STAT3信号通路,降低炎症因子水平,减轻肾脏炎症反应和纤维化进程,从而延缓CKD进展.

Objective To investigate the mechanism of Haikun Shenxi Capsules in attenuating renal fibrosis in chronic kidney disease(CKD)based on IL-6/JAK2/STAT3 signaling pathway.Methods Totally 48 male C57BL/6 mice were randomly divided into the blank group,model group,Haikun Shenxi Capsules group(200 mg/kg)and losartan potassium group(10 mg/kg).Except for the blank group,mice in the other groups were fed a 0.2%adenine-containing diet for 4 weeks to induce CKD.Mice in the treatment groups received the corresponding drugs by daily gavage from the start of model induction,once a day for 8 weeks.The levels of serum creatinine,blood urea nitrogen,serum uric acid,alanine aminotransferase(ALT)and aspartate aminotransferase(AST)were detected;renal index and urinary albumin creatinine ratio(ACR)were detected;HE,Masson and Sirius red staining were used to observe the renal morphology and fibrosis,renal ultrastructure was observed by transmission electron microscopy,the expressions of Fibronectin and E-cadherin were detected by immunofluorescence,the key targets and pathways were screened by transcriptomics,and the contents of interleukin(IL)-6,IL-1β and tumor necrosis factor(TNF)-α in renal tissue were detected by ELISA,the mRNA expressions of IL-6,JAK2,STAT3 were detected by RT-qPCR,and the protein expressions of IL-6,JAK2,p-JAK2,STAT3 and p-STAT3 were detected by Western blot.Results Compared with the blank group,the levels of serum creatinine,blood urea nitrogen,serum uric acid,ALT,renal index and ACR in the model group significantly increased(P<0.05,P<0.01);the renal tissue structure was damaged,which showed that the renal tubular lumen was dilated,the brush border fell off,the interstitial collagen fibers proliferated,and the collagen deposition increased significantly(P<0.01);the renal tubular epithelial cells were necrotic,cytoplasmic electron density decreased,vacuolation and nucleolysis,the expression of Fibronectin was significantly increased,and the expression of E-cadherin significantly decreased(P<0.01).Compared with the model group,the levels of serum creatinine,blood urea nitrogen,blood uric acid,renal index and ACR in Haikun Shenxi Capsules group and losartan potassium group significantly decreased(P<0.05,P<0.01);the vacuolation,lumen expansion and collagen deposition of renal tubules were improved,the expression of Fibronectin significantly decreased,and the expression of E-cadherin significantly increased(P<0.05,P<0.01).Transcriptomic sequencing showed that Haikun Shenxi Capsules could regulate 295 key differentially expressed genes related to CKD that were primarily enriched in the JAK-STAT signaling pathway.ELISA showed that both Haikun Shenxi Capsules and losartan potassium could significantly reduce the contents of renal IL-6,IL-1β and TNF-α(P<0.05,P<0.01).RT-qPCR showed that both treatments reduced the mRNA expression of IL-6 and STAT3(P<0.05,P<0.01).Western blot analysis further showed that both treatments could suppress IL-6 protein expression and the phosphorylation of JAK2 and STAT3(P<0.05,P<0.01).Conclusion Haikun Shenxi Capsules may delay CKD progression by inhibiting the IL-6/JAK2/STAT3 signaling pathway,reducing inflammatory cytokine levels,and thereby attenuating renal inflammation and fibrosis.

宿家铭;蔡丰翼;臧欣悦;柳红芳;董昭熙;刘家佑;徐哲宇;李法威;梅洁;于欣卉;胡济源

北京中医药大学东直门医院,北京 100700||中医内科学教育部重点实验室,北京 100700北京中医药大学东直门医院,北京 100700||中医内科学教育部重点实验室,北京 100700北京中医药大学东直门医院,北京 100700||中医内科学教育部重点实验室,北京 100700北京中医药大学东直门医院,北京 100700||中医内科学教育部重点实验室,北京 100700北京中医药大学东直门医院,北京 100700||中医内科学教育部重点实验室,北京 100700北京中医药大学东直门医院,北京 100700||中医内科学教育部重点实验室,北京 100700北京中医药大学东直门医院,北京 100700||中医内科学教育部重点实验室,北京 100700北京中医药大学东直门医院,北京 100700||中医内科学教育部重点实验室,北京 100700北京中医药大学东直门医院,北京 100700||中医内科学教育部重点实验室,北京 100700北京中医药大学东直门医院,北京 100700||中医内科学教育部重点实验室,北京 100700北京中西医结合医院,北京 100038

医药卫生

海昆肾喜胶囊慢性肾脏病肾纤维化转录组学IL-6/JAK2/STAT3信号通路小鼠

Haikun Shenxi Capsuleschronic kidney diseaserenal fibrosistranscriptomicsIL-6/JAK2/STAT3 signaling pathwaymice

《中国中医药信息杂志》 2026 (9)

48-55,8

国家自然科学基金(82574945)中华中医药学会联合攻关项目(2023DYPLHGG-06)北京中医药大学研究生自主科研课题(ZJKT2024004)中国中医科学院"中国中医药联合研究生院"科教专项(CI2023C003LH)

10.19879/j.cnki.1005-5304.202602102

评论